A4250 for treating progressive familial intrahepatic cholestasis [ID1570]
In development [GID-HST10031] Expected publication date: TBC
Search results
517 results
-
-
Palovarotene for preventing heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID3739]
In development [GID-HST10032] Expected publication date: TBC
-
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]
In development [GID-HST10033] Expected publication date: TBC
-
OTL-200 for treating metachromatic leukodystrophy [ID1666]
In development [GID-HST10028] Expected publication date: TBC
-
Avalglucosidase alfa for treating late-onset glycogen storage disease type II [ID3737]
In development [GID-HST10030] Expected publication date: TBC
-
Lysosomal acid lipase deficiency - sebelipase alfa [ID737]
In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC
-
Afamelanotide for treating erythropoietic protoporphyria [ID927]
In development [GID-HST10009] Expected publication date: TBC
-
Ravulizumab for treating paroxysmal nocturnal haemoglobinuria [ID1457]
In development [GID-HST10023] Expected publication date: TBC
-
Human alpha1-proteinase inhibitor for treating emphysema ID856
In development [GID-HST10017] Expected publication date: TBC
-
Metreleptin for treating lipodystrophy (ID861)
In development [GID-HST10011] Expected publication date: 13 January 2021
-
Velmanase alfa for treating alpha-mannosidosis [ID800]
In development [GID-HST10010] Expected publication date: TBC
-
Volanesorsen for treating familial chylomicronaemia syndrome [ID1326]
In development [GID-HST10015] Expected publication date: TBC
-
Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473]
In development [GID-HST10026] Expected publication date: 25 March 2021
-
DHT pilot: Zio XT for detecting cardiac arrhythmias
In development [GID-MT534] Expected publication date: 06 October 2020
-
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)
In development [GID-MT526] Expected publication date: TBC
-
Alpha Stim AID
In development [GID-MT542] Expected publication date: 27 January 2021
-
The MAGEC system for spinal lengthening in children with scoliosis
In development [GID-MT544] Expected publication date: 15 September 2020
-
DHT pilot: myCOPD for self-management of chronic obstructive pulmonary disease (COPD)
In development [GID-MT531] Expected publication date: TBC
-
Endo-Sponge for treating colorectal anastomotic leakage
In development [GID-MT539] Expected publication date: 30 November 2020
-
Axonics sacral neuromodulation system for bladder control in people with symptoms of overactive bladder
In development [GID-MT530] Expected publication date: 31 August 2020
-
The PLASMA system for transurethral resection of the prostate
In development [GID-MT545] Expected publication date: 14 December 2020
-
Danis Stent for acute oesophageal variceal bleeds
In development [GID-MT537] Expected publication date: 30 March 2021
-
SEM Scanner 200 for pressure ulcer prevention
In development [GID-MT533] Expected publication date: 05 October 2020
-
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia
In development [GID-MT548] Expected publication date: 10 March 2021
-
Leukomed Sorbact for preventing surgical site infection
In development [GID-MT541] Expected publication date: 27 January 2021
-
Peezy Midstream for urine collection
In development [GID-MT538] Expected publication date: 11 March 2021
-
V.A.C. VERAFLO Therapy System for acute infected or chronic wounds that are failing to heal
In development [GID-MT543] Expected publication date: 27 January 2020
-
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [ID1477]
In development [GID-TA10448] Expected publication date: 07 October 2020
-
Mental health community settings
In development [GID-SGWAVE0702] Expected publication date: TBC
-
Inpatient mental health settings
In development [GID-SGWAVE0701] Expected publication date: TBC
-
Community nursing care settings
In development [GID-SGWAVE0700] Expected publication date: TBC
-
Management and organisational approaches to safe staffing
In development [GID-SGWAVE0761] Expected publication date: TBC
-
Accident and emergency departments
In development [GID-SGWAVE0762] Expected publication date: TBC
-
Lung cancer (non-small cell, advanced, inoperable) - liposomal cisplatin (with chemotherapy) [ID657]
In development [GID-TAG496] Expected publication date: TBC
-
Pancreatic cancer (metastatic, untreated) - liposomal cisplatin (with gemcitabine) [ID658]
In development [GID-TAG494] Expected publication date: TBC
-
Diabetes - buccal insulin [ID311]
In development [GID-TAG244] Expected publication date: TBC
-
Cardiac transplantation (rejection) - everolimus [ID114]
In development [GID-TAG232] Expected publication date: TBC
-
Third molars (impacted) - prophylactic removal [ID898]
In development [GID-TAG525] Expected publication date: TBC
-
BCX7353 for preventing acute angioedema attacks in people 12 and over with hereditary angioedema [ID1624]
In development [GID-TA10650] Expected publication date: TBC
-
Lacosamide for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [ID1687]
In development [GID-TA10664] Expected publication date: TBC
-
Cenobamate for focal onset seizures in epilepsy [ID1553]
In development [GID-TA10661] Expected publication date: TBC
-
Recombinant human parathyroid hormone for treating hypoparathyroidism [1094]
Technology appraisal [TA625] Published date: 04 March 2020
-
Neuroendocrine tumours (metastatic, unresectable, progressive) - everolimus and sunitinib [ID858]
In development [GID-TA10024] Expected publication date: 28 June 2017
-
Waldenstrom's macroglobulinaemia - ibrutinib [ID884]
In development [GID-TA10046] Expected publication date: 22 November 2017
-
Short bowel syndrome - teduglutide [ID885]
In development [GID-TA10048] Expected publication date: TBC
-
Sodium thiosulfate for preventing hearing loss in people with cancer who are under 18 and having cisplatin chemotherapy [ID1001]
In development [GID-TA10611] Expected publication date: TBC
-
Omalizumab for treating chronic rhinosinusitis with nasal polyps [ID1650]
In development [GID-TA10558] Expected publication date: TBC
-
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs [ID1658]
In development [GID-TA10561] Expected publication date: TBC
-
Ravulizumab for treating atypical haemolytic uraemic syndrome (aHUS) [ID1530]
In development [GID-TA10564] Expected publication date: TBC
-
Roxadustat for treating anaemia in people with chronic kidney disease [ID1483]
In development [GID-TA10610] Expected publication date: TBC